ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 67 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $72,000 | -59.8% | 13,620 | -63.4% | 0.00% | – |
| Q1 2021 | $179,000 | -88.4% | 37,220 | -89.5% | 0.00% | -100.0% |
| Q4 2020 | $1,537,000 | +879.0% | 355,079 | +829.0% | 0.00% | – |
| Q3 2020 | $157,000 | +201.9% | 38,220 | +88.4% | 0.00% | – |
| Q2 2020 | $52,000 | -28.8% | 20,285 | -20.2% | 0.00% | – |
| Q1 2020 | $73,000 | -79.0% | 25,416 | -72.4% | 0.00% | – |
| Q4 2019 | $348,000 | -60.6% | 91,978 | -46.7% | 0.00% | -100.0% |
| Q3 2019 | $883,000 | -44.0% | 172,678 | -32.1% | 0.00% | 0.0% |
| Q2 2019 | $1,577,000 | +730.0% | 254,478 | +845.0% | 0.00% | – |
| Q1 2019 | $190,000 | -91.9% | 26,930 | -90.2% | 0.00% | -100.0% |
| Q4 2018 | $2,339,000 | -36.9% | 274,050 | +48.1% | 0.00% | +100.0% |
| Q3 2018 | $3,704,000 | +60.8% | 185,088 | +107.6% | 0.00% | 0.0% |
| Q2 2018 | $2,303,000 | -48.9% | 89,167 | -52.7% | 0.00% | -50.0% |
| Q1 2018 | $4,507,000 | -73.7% | 188,633 | -62.7% | 0.00% | -81.8% |
| Q4 2017 | $17,159,000 | +1073.7% | 506,369 | +632.7% | 0.01% | +1000.0% |
| Q3 2017 | $1,462,000 | +364.1% | 69,106 | +281.8% | 0.00% | – |
| Q2 2017 | $315,000 | +258.0% | 18,098 | +253.8% | 0.00% | – |
| Q1 2017 | $88,000 | -48.8% | 5,116 | -50.3% | 0.00% | – |
| Q4 2016 | $172,000 | +109.8% | 10,298 | +104.0% | 0.00% | – |
| Q3 2016 | $82,000 | -81.3% | 5,047 | -82.6% | 0.00% | – |
| Q2 2016 | $439,000 | -49.1% | 29,084 | -51.3% | 0.00% | -100.0% |
| Q1 2016 | $863,000 | +387.6% | 59,765 | +845.9% | 0.00% | – |
| Q4 2015 | $177,000 | -89.1% | 6,318 | -93.5% | 0.00% | -100.0% |
| Q3 2015 | $1,628,000 | -13.3% | 97,399 | +35.9% | 0.00% | 0.0% |
| Q2 2015 | $1,877,000 | – | 71,646 | +7164500.0% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q4 2014 | $210,000 | +187.7% | 12,135 | +207.4% | 0.00% | – |
| Q3 2014 | $73,000 | -61.6% | 3,948 | -62.2% | 0.00% | – |
| Q2 2014 | $190,000 | – | 10,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |